Apricus Biosciences, Inc. Announces Merger Agreement with Seelos Therapeutics In All-Stock Transaction; Apricus Shareholders To Own ~14% Of The Combined Co. With Seelos Owning ~86% Of The Combined Co.
Benzinga_Newsdesk